Canopy Growth(CGC)
icon
搜索文档
Should You Buy Canopy Growth (CGC) Stock Before May 30?
investorplace.com· 2024-05-18 03:30
On paper, stakeholders of cannabis operator Canopy Growth (NASDAQ:CGC) have plenty of reasons to smile. Anticipation of major marijuana policy shifts culminated in a recent announcement by President Joe Biden that the government will reclassify the controversial plant. However, questions still dog CGC stock ahead of Canopy’s first-quarter earnings report. One of the most significant developments regarding the legalization movement came Thursday when President Biden posted a video message regarding his admin ...
Strength Seen in Canopy Growth (CGC): Can Its 11.0% Jump Turn into More Strength?
zacks.com· 2024-05-17 15:31
Canopy Growth Corporation (CGC) shares ended the last trading session 11% higher at $11. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 52.7% gain over the past four weeks. The surge in Canopy Growth's shares can be attributed to the U.S. Government's proposal to reclassify marijuana from Schedule I (reserved for drugs with a high potential for abuse) to Schedule III (reserved for drugs with a moderate to low pote ...
Canopy Growth to Report Fourth Quarter and Fiscal Year 2024 Financial Results on May 30, 2024
prnewswire.com· 2024-05-16 19:30
SMITHS FALLS, ON, May 16, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis, will release its financial results for the fourth quarter and fiscal year 2024 ended March 31, 2024 before financial markets open on May 30, 2024. Following the release of its fourth quarter and fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and ...
May 2024 Watchlist: Top Canadian Cannabis Stocks Heating Up the Market
MarijuanaStocks· 2024-05-14 21:30
Key Canadian Cannabis Stocks to Watch in Mid-May 2024 As we explore the bustling Canadian cannabis market, several marijuana stocks stand out this week, warranting a closer look. These companies, thriving amid a globally expanding industry, have shown resilience and innovation. Recent statistics reveal the global cannabis market could reach USD 197.74 billion by 2028, according to Grand View Research. This forecast underscores significant growth potential, driven by increasing legalization and medical usage ...
The Biden Administration Plans to Reschedule Marijuana: 3 Things You Need to Know Before Rushing to Buy Tilray Brands and Canopy Growth Stock
The Motley Fool· 2024-05-11 23:15
Pot stocks can sometimes trade like meme stocks, and investors need to be careful, or they may incur significant losses. Cannabis stocks were surging last week on the news that the Drug Enforcement Administration (DEA) is going to reclassify marijuana. It will no longer be a Schedule I drug alongside heroin and LSD. Instead, it will be moved to Schedule III, where ketamine and certain anabolic steroids are grouped. Usually, when there's some positive news around marijuana reform, shares of Tilray Brands (TL ...
Ready To Invest? Here Are 3 Top Marijuana Stocks For You
MarijuanaStocks· 2024-05-10 21:04
The Best 3 Marijuana Stocks For Your 2024 Watchlist What will happen to marijuana stocks if cannabis does not get rescheduled? Some see this as a possibility and investors want to be prepared. With all the recent talks of cannabis being dropped from a scheduled 1 to a class 3 substance it has led to a rise in trading. The speculation of what’s next to come is also feeding into momentum pouring into the sector. The goal should be the reclassification of cannabis and putting it into the same place as alcohol ...
Canopy Growth begins expansion into US with Wana Brands and Jetty Extracts acquisitions
Proactive Investors· 2024-05-07 23:51
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...
Canopy Growth Confirms Canopy USA's Exercise of Options to Acquire Wana and Jetty
Prnewswire· 2024-05-07 19:30
SMITHS FALLS, ON, May 7, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today confirmed that Canopy USA, LLC ("Canopy USA") has exercised the options to acquire Wana and Jetty (each as defined below). The exercise of these options is a critical next step to enable Canopy USA to fulfill its intent to establish a leading, brand-focused powerhouse. It is also expected that once completed, these acquisitions will enable Canopy USA to realize compelling ...
Canopy Growth Announces Financing to Further Strengthen Balance Sheet Including Approximately US$50 Million of New Gross Proceeds
Prnewswire· 2024-05-03 19:30
C$27.5 Millon of Debt Extended from 2025 to 2029 Providing Additional Balance Sheet Flexibility SMITHS FALLS, ON, May 3, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), today announced that on May 2, 2024, it entered into an exchange and subscription agreement (the "Agreement") with a single institutional investor (the "Investor") pursuant to which Canopy Growth is expected to receive gross proceeds of approximately US$50 million and exchange appro ...
Why Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered
The Motley Fool· 2024-05-02 03:13
Investors are taking profits on marijuana stocks today, but the long-term trend still looks up. Easy come, easy go. Yesterday, shares of cannabis companies like Canopy Growth (CGC -25.96%), Tilray Brands (TLRY -17.01%), and Cronos Group (CRON -7.14%) all soared on news that the U.S. Drug Enforcement Administration (DEA) has agreed to recommend downgrading marijuana from a Schedule I drug to a Schedule III drug. Already today, the high is starting to wear off. As of 11:15 a.m. ET Wednesday, Canopy Growth sto ...